Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 174

Results For "patient"

4831 News Found

ZIM Laboratories and Globalpharma collaborate to commercialize oral thin film products in GCC
News | April 09, 2025

ZIM Laboratories and Globalpharma collaborate to commercialize oral thin film products in GCC

This partnership encompasses dossier licensing, bulk product supply, and the licensing of ZIM Labs’ proprietary Oral Thin Film technology platform, ThinOral


Honeywell launches AI-assisted automation platform for life sciences manufacturing industry
Digitisation | April 08, 2025

Honeywell launches AI-assisted automation platform for life sciences manufacturing industry

Introduces revolutionary approach to workflow management to enhance operational efficiency and optimize process efficiency


NATCO Pharma updates on legal proceedings on Risdiplam launch in India
News | April 08, 2025

NATCO Pharma updates on legal proceedings on Risdiplam launch in India

NATCO has decided to price the product at Rs.15, 900 MRP consistent with the company’s stand before the court


Lyka Labs secures Indian patent for Pregabalin Gel 8%
News | April 08, 2025

Lyka Labs secures Indian patent for Pregabalin Gel 8%

Pregabalin Gel 8% is a novel topical solution for diabetic neuropathic pain


Delhi becomes 35th state/UT to implement AB PM-JAY
Policy | April 07, 2025

Delhi becomes 35th state/UT to implement AB PM-JAY

Nadda noted that on the basis of economic caste census, 50 crore people were brought under this scheme


Plex Research partners With Ginkgo Bioworks on AI powered drug discovery to identify novel disease mechanisms
News | April 07, 2025

Plex Research partners With Ginkgo Bioworks on AI powered drug discovery to identify novel disease mechanisms

Findings likely to generate hypotheses about potential new uses of drugs


Sun Pharma introduces Fexuclue in India for treatment of Erosive Esophagitis
News | April 07, 2025

Sun Pharma introduces Fexuclue in India for treatment of Erosive Esophagitis

Fexuprazan has the longest half-life of 9 hours among potassium-competitive acid blockers


Enhertu approved in EU in post-ET breast cancer
Drug Approval | April 04, 2025

Enhertu approved in EU in post-ET breast cancer

Approval brings AstraZeneca and Daiichi Sankyo’s Enhertu earlier in the treatment of HR-positive, HER2-low breast cancer and broadens the eligible patient population to those with HER2-ultralow disease


Lupin acquires UK-based Renascience Pharma for £12.3 million
News | April 04, 2025

Lupin acquires UK-based Renascience Pharma for £12.3 million

The portfolio includes branded injectable cephalosporines for infectious diseases